Hypopituitarism after gamma knife radiosurgery for pituitary adenoma
- 24 May 2017
- journal article
- research article
- Published by Taylor & Francis Ltd in Endocrine Research
- Vol. 42 (4), 318-324
- https://doi.org/10.1080/07435800.2017.1323913
Abstract
Purpose: The aim of the study was to investigate the incidence of and risk factors for hypopituitarism after gamma knife radiosurgery (GKRS) for pituitary adenoma. Materials and Methods: We conducted a retrospective analysis of the pituitary function of 90 patients who underwent GKRS for pituitary adenoma at the University Hospital Centre Zagreb between 2003 and 2014. Twenty seven of them met the inclusion criteria and the others were excluded from the study due to pituitary insufficiency which was present before GKRS. Eighteen patients had non-functioning and 9 patients had secretory adenomas. Median patients’ age was 56 years (24–82). GKRS was performed using the Leksell gamma knife Model C. The median prescription radiation dose was 20 Gy (15–25) and the median tumor volume size was 3.4 cm3 (0.06–16.81). New onset hypopituitarism was defined as a new deficit of one of the three hormonal axes (corticotroph, thyreotroph, or gonadotroph) ≥3 months following GKRS. SPSS was used for statistical analysis, with the significance level at P<0.05. Results: During the median follow-up period of 72 months (range 6–144), 30% of patients developed new hypopituitarism after GKRS. This corresponds to incidence of one new case of hypopituitarism per 15 patient-years. Age, gender, tumor function, tumor volume, suprasellar extension, prescription dose of radiation, as well as dose-volume to the pituitary gland, stalk and hypothalamus were not predictive factors for the development of hypopituitarism. Conclusions: In our cohort of patients with pituitary tumors who underwent GKRS, 30% developed new hypopituitarism during the follow-up period.Keywords
This publication has 28 references indexed in Scilit:
- Long term toxicity and prognostic factors of radiation therapy for secreting and non-secreting pituitary adenomasRadiation Oncology, 2013
- Long-term Outcomes After Gamma Knife Stereotactic Radiosurgery for Nonfunctional Pituitary AdenomasNeurosurgery, 2011
- Long-term Outcomes After Gamma Knife Radiosurgery for Patients With a Nonfunctioning Pituitary AdenomaNeurosurgery, 2011
- Gamma Knife Radiosurgery for Patients with Prolactin-Secreting Pituitary AdenomasWorld Neurosurgery, 2010
- Factors Associated With Endocrine Deficits After Stereotactic Radiosurgery of Pituitary AdenomasNeurosurgery, 2010
- Efficacy and tolerability of gamma knife radiosurgery in acromegaly: a 10‐year follow‐up studyClinical Endocrinology, 2009
- Radiation-induced hypopituitarismEndocrine-Related Cancer, 2009
- Radiation-induced hypopituitarism after cancer therapy: who, how and when to testNature Clinical Practice Endocrinology & Metabolism, 2009
- The efficacy of fractionated radiotherapy and stereotactic radiosurgery for pituitary adenomasCancer, 2007
- Stereotactic radiosurgery for pituitary adenomas: an intermediate review of its safety, efficacy, and role in the neurosurgical treatment armamentariumJournal of Neurosurgery, 2005